Atherectomy Devises Market Analysis Overview:
In a recent research report by Market Research Community, the atherectomy devices market is expected to surpass USD 6.35 Billion by the year 2030, from USD 4.20 Billion in 2021.
Atherectomy devices are made to remove some plaque or other material from an artery with atherosclerosis. The first of these devices to receive U.S. approval was the directional coronary atherectomy.
Rotational atherectomy tools also hold a significant market share in 2021. Approximately nine months after the treatment, about 96% of cases do not require therapeutic support. Over the next eight years, it is projected that this will provide rotational devices with a competitive edge and increase their atherectomy devices market share. The reimbursement scenario is also advantageous for atherectomy as a growth factor in the atherectomy devices market. The 2019 reimbursement scenario was published by the Centers for Medicare and Medicaid Services in November 2018. The hospital outpatient payment system reimbursement rates for atherectomy were cut by 8%.
Top Key Players of the Atherectomy Devises Market:
Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Koninklijke Philips N.V, Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.
Over the next eight years, Asia Pacific is expected to experience the fastest growth. Target illnesses have increased as a result of factors such as socioeconomic changes, bad food, smoking, alcohol intake, and an aging population. In the region, PAD afflicted almost 97 million individuals in 2015. By 2019, this amount is anticipated to reach 111 million. This demonstrates the enormous potential for market expansion in the area.
The Atherectomy Devices market is projected to grow at a significant pace reaching a CAGR of approximately 4.7%, over the forecast period of 2022–2030, despite a considerable fall in Type sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
Type Covered in This Report Are:
Directional atherectomy
Rotational atherectomy
Orbital atherectomy
Laser atherectomy
Regional Analysis:
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
By End User:
Hospitals and Surgical Centers, Ambulatory Care Centers, Other End Users
The study is consolidated into major segments and further into sub-segments, such as by type (directional atherectomy, rotational atherectomy, orbital atherectomy, laser atherectomy) Atherectomy Devises Market Industry, by end use (hospitals and surgical centers, ambulatory care centers, other end users) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
The research provides answers to the following key questions:
- What is the estimated growth rate of the market for the forecast period 2022 - 2030? What will be the market size during the estimated period?
- What are the key driving forces responsible for shaping the fate of the Atherectomy Devises Market during the forecast period?
- Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Atherectomy Devises Market?
- What are the prominent market trends influencing the development of the Atherectomy Devises Market across different regions?
- What are the major threats and challenges likely to act as a barrier in the growth of the Atherectomy Devises Market?
- What are the major opportunities the market leaders can rely on to gain success and profitability?
Contact:
